Personen
Prof. Dr. med. Benjamin Meder

Deputy Medical Director (Klinik für Kardiologie, Angiologie, Pneumologie)
Head of the Institute (Institut für Cardiomyopathien Heidelberg)
Head of the Institute (Herzkatheter)
Research Group Leader (Molecular Genetics Laboratory)


Molecular Genetics Laboratory Informatics for Life

Medical/Professional background

since 2017

Managing Senior Physician

since 2015

Associate Professor (Priv.-Doz.) of Internal Medicine

since 2014

Senior Physician

since 2012

Medical Specialist for Internal Medicine and Cardiology

since 2012

Free journalist (medicine and science)

Scientific background

since 2011

Head of Genomic Research at the Department of Internal Medicine III, University Hospital of Heidelberg

since 2009

Research group leader, Laboratory of Molecular Genetics, Department of Internal Medicine III, University Hospital of Heidelberg

2005 – 2009

Postdoctoral research fellow in the group for Functional Genomics (Prof. W. Rottbauer), Department of Internal Medicine III, University of Heidelberg

2003 – 2004

Scientific Assistant, Laboratory of Engineering & Bioinformatics, Perfusion Technologies GmbH

2001 – 2004

Research doctorate, Department of Cardiology, University Hospital of Freiburg

1998 – 2005

Medical School, Albert-Ludwigs-University of Freiburg

Commendations

since 2017

Winterstein Science Award of the German Heart Foundation

2009 – 2011

Research fellowship (Young Investigator Award) of the Medical Faculty, University of Heidelberg

since 2010

Winterstein Science Award of the German Heart Foundation

2009

Best Poster Award, 7th Dutch-German Meeting of the Molecular Cardiology Groups

2003 – 2005

Scholarship of Bayer Foundations, Leverkusen, Germany

2001 – 2005

E-fellows scholarship, Munich, Germany

Professional memberships

since 2017

Cardiolinc Consortium Member

since 2016

Fellow of the European Society of Cardiology (FESC;)

since 2016

Translational Research Committee Member of the Heart Failure Association

since 2015

Genomics Proteomics Bioinformatics

since 2014

Editorial Board Member Frontiers Cardiovascular Medicine.

since 2013

DGK working group 12 “Cardiomyopathies” – Nucleus member

Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V.

DGK working group 8 „Genetik und Molekularbiologie kardiovaskulärer Erkrankungen“

Gut-Glut Heidelberg e.V.

Deutscher Fachjournalisten-Verband (German Association of Specialized Journalists)

Offices and posts held

2011 – 2013

Coordinator of the Innovation Alliance “Subgenome Fractionation for High-throughput Sequencing”

since 2013

Coordinator Cardiomyopathy Group DZHK Registries

since 2013

Steering committee of the Network for Congenital Heart Diseases

Coordinator Cardiomyopathy Research Board & Institute for Cardiomyopathies Heidelberg (ICH.)

Klinische Ausbildung

since 2015

DGK qualification Interventional Cardiology

Klinische Spezialität

Kardiomyopathien:

  • Dilatative Cardiomyopathie (DCM)
  • Linksventrikuläre Noncompaction-Cardiomyopathie (LVNC)
  • Arrhytmogene Rechtsventrikuläre Cardiomyopathie (ARVC)
  • Tako Tsubo Syndrom

Klinische Schwerpunkte

Interventionelle Kardiologie

Kardiomyopathien

Experimentelle Schwerpunkte

Genetik und Epigenetik von Kardiomyopathien

Translationale Biotechnologie

Omics-basierte Biomarker

Funding

2017 – 2020

Promise (BMBF) ERA-CVD Detectin-HF (EU, BMBF).

2016 – 2019

Promise (BMBF) ERA-CVD Detectin-HF (EU, BMBF 2017-2020).

2016 – 2019

eMed Systems Biology CaRNAtion (BMBF)

2014 – 2019

Klaus Tschira Foundation

2013 – 2017

BestAgeing (EU FP7)

2012 – 2014

“Translational Biotechnology” (Siemens AG)

2011 – 2013

Innovationsfond FRONTIER “Development of miRNA-based biomarkers” (University of Heidelberg)

2010 – 2013

INSIGHT DCM (BMBF/EU); INHERITANCE – Genetics of Dilated Cardiomyopathy (EU FP7);

2009 – 2013

INSIGHT DCM (BMBF/EU); INHERITANCE – Genetics of Dilated Cardiomyopathy (EU FP7);

2008 – 2013

NGFN Plus project “DNA and Mutation-Screening Platform” (BMBF)

since 2012

German Center for Cardiovascular Research – DZHK (BMBF)

2008 – 2012

NGFN Transfer project “Targeted Next-Generation Sequencing” (BMBF)

2009 – 2010

Start-up of an Excellence Cluster: “Heart and Cancer” (MWK)

Patents Applications

US 61/326,043 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;

EP 10 004 190.4 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;

US 13/642,321 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;

EP 11715666.1 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;

PCT/EP2011/001999 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;

EP 101 851 36.8 Complex miRNS sets as novel biomarkers for an acute coronary syndrome;

EP 11169192.9 MicroRNA signatures als Biomarker für die dilatative Kardiomypathie (DCM) und Herzinsuffizienz; PCT/EP2012/060927 Complex set of miRNAs as noninvasive biomarkers for dilated cardiomyopathy;

13 709 132.8 Epigenetic signatures as markers for cardiomyopathies and myocardial insufficiensies;

PCT/EP2013/055267 Epigenetic signatures as markers for cardiomyopathies and myocardial insufficiensies;

EP12163180.8 Complex sets of miRNAs as non-invasive biomarkers for early diagnosis of acute myocardial infarction;

PCT/EP2013/057118 Complex sets of miRNAs as non-invasive biomarkers for early diagnosis of acute myocardial infarction;

EP 13168684.2 MICRORNA as non-invasive biomarkers for heart failure

Treatment/Procedure (specialisation)

Diseases (specialisation)